TCL Archive Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light December 5, 2014
TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive NCI Plans To Issue Frederick Operations Contract As Sole-Source To SAIC-Frederick Inc. For Up To 10 Years. November 10, 2006